The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.
about
Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland ChinaRecent Progress towards Novel EV71 Anti-Therapeutics and VaccinesIs a multivalent hand, foot, and mouth disease vaccine feasible?Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic MouseEfficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in MiceEV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDCEV71 vaccine, an invaluable gift for children.Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches.Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNAEV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challengeUpdate of enterovirus 71 infection: epidemiology, pathogenesis and vaccine.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.Review of enterovirus 71 vaccines.Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.Cost-effectiveness of a national enterovirus 71 vaccination program in China.A Potent Virus-Specific Antibody-Secreting Cell Response to Acute Enterovirus 71 Infection in Children.Epidemiology and etiology of hand, foot, and mouth disease in Fujian province, 2008-2014.Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children.Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015.Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth diseaseAnalysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development
P2860
Q26774357-3143173F-DBFE-419C-B12D-61E59F3E3FBCQ26775734-68E7454F-6047-4223-B5C6-60C05B3B92F7Q27010349-37DE8FA3-CF2B-481F-B560-51FABD50CF2BQ27321616-7F8BFE0A-2CB3-4820-9B7D-DC0ED994A73CQ28606867-AF073D94-D49D-4206-89AA-8AAB47F4C303Q30383172-3A167EF5-ACA5-487F-B690-B1D4E3E5030CQ30922949-90B0CF99-5EFA-4942-A83E-EEFA6A52C5DCQ33806668-E37FDB42-FA18-4B82-8E4B-3EE7EB2206C0Q33887710-792B119E-B495-4D63-B465-57E487703491Q34289974-E2D6E099-52F5-4CBE-89EB-A106D0CD0096Q34540559-8E5555AF-B328-4D87-BC28-9AAEE862C7EDQ35779269-732C512F-2F44-47A6-9078-1D724B9F6ECCQ35806448-8DF9A321-ABF3-4B5D-96C9-A7F1C5A73C56Q35925175-E2CC04E8-C33D-4A40-B847-50357627137DQ35991169-C8B5BEA2-7B8D-4D7D-9C5E-91B0789E2C18Q36496385-C17ED344-6593-465D-BD68-CA819269802EQ38192021-3B72B78E-3144-4B7A-BEF2-44AB948DEBF1Q38195326-4CDC6EE1-4026-45B0-B261-99989D7FEBEBQ38263484-0831451F-8B0B-466E-A0FE-E703C506B6C0Q38840182-5069ED2C-C140-4DE6-BD2A-8578E0B4C142Q40047717-FCA50250-F9BA-4AAB-B368-42EE79688D75Q40168001-B0458788-3BD9-4895-AB41-F1692EEDD3E2Q40475005-D6892731-B8A6-4E72-9B94-38674342750CQ40955592-C4622BFC-FFBF-48CC-83AF-E196585D186BQ49820089-913B31C0-EEEA-462E-A132-7D946D821AA4Q55967992-FA6D6E88-CE38-4437-93DC-DA16C5FA167DQ57490132-6C6001D0-2DF0-43B3-9236-701C767021ABQ59139034-DB3DEBC1-1837-4F08-B9DC-3FCC9A0A5C28
P2860
The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The cross-neutralizing activit ...... chinese infants and children.
@en
type
label
The cross-neutralizing activit ...... chinese infants and children.
@en
prefLabel
The cross-neutralizing activit ...... chinese infants and children.
@en
P2093
P2860
P1433
P1476
The cross-neutralizing activit ...... chinese infants and children.
@en
P2093
Fengcai Zhu
Jingxin Li
Junzhi Wang
Lisheng Yang
Ningshao Xia
Qunying Mao
Tong Cheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0079599
P407
P577
2013-11-19T00:00:00Z